Tag: VENTANA PD-L1

Home / VENTANA PD-L1

Categories

Atezolizumab is approved by FDA as adjuvant treatment for non-small cell lung cancer

Nov 2021: The Food and Drug Administration has approved atezolizumab (Tecentriq, Genentech, Inc.) for adjuvant treatment in patients with stage II to IIIA non-small cell lung cancer (NSCLC) whose tumo...
ventana-pd-l1

We Are Online! Chat With Us!
Scan the code